Lung cancer research concludes that early diagnosis as key for improving survival

	Tweet

Research published in the June edition of the Journal of Thoracic Oncology sought to investigate the time trends of surgical outcomes of patients with non-small cell lung cancer (NSCLC) between 1979 and 2008. The incidence of lung cancer continues to rise; therefore, countermeasures to decrease death rates have become an important public health issue. After analyzing the time trends, researchers postulated that the increase of patients diagnosed with early stages of adenocarcinoma contribute to the favorable prognostic and survival outcomes. Furthermore, the research highlights that prognosis of NSCLC patients has improved in recent years.

The current treatment strategy for NSCLC depends on clinical staging, to which surgical resection is the first-line treatment for stages I to II. Moreover, only a few of the stage III cases are treated surgically. While the standards for surgical treatment have remained unchanged for a few decades, there have been a number of advances in perioperative, anesthetic, and intraoperative management, specifically over the past three decades.

To gather insights on the correlation to overall survival, the present study retrospectively investigated the clinicopathologic features of NSCLC patients who underwent surgery and the corresponding time trends of surgical outcomes. 

To draw the analysis, researchers reviewed records of nearly 1,500 patients who underwent resection of NSCLC during the following five time intervals: (1) 1979 – 1988, (2) 1989 – 1993, (3) 1994 – 1998, (4) 1999� and (5) 2004�. Overall results showed that the number of patients who underwent a resection, the percentage of pathologic stage IA lung cancers, their subsequent survival and the percentage of adenocarcinoma have all progressively increased over the almost 30 year span. The only variable that decreased was tumor size, indicating that diagnoses were increasingly earlier. Most notably survival rates for 1999-2004 and 2004-2008 were significantly better than any of the previous three periods.

“The prognosis of NSCLC patients has been remarkably improved in recent years,” explains lead study investigator Takeshi Hanagiri, MD, PhD. “The increase of patients with diagnosed with adenocarcinoma in the early stages is thought to strongly contribute to the favorable results, further reiterating the key factor of early diagnosis for improving the survival of lung cancer patients after surgical treatment. Thus, early diagnosis remains a key factor for improving the survival of lung cancer patients after surgical treatment”

###

Journal of Thoracic Oncology (JTO) – (journals.lww.com/jto)

The JTO is a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer. The JTO is the official monthly journal of the International Association for the Study of Lung Cancer (IASLC.org) and emphasizes a multidisciplinary approach, including original research (clinical trials and translational or basic research), reviews and opinion pieces.

---
Contact: Megan Richter
mrichter@spectrumscience.com
202-587-2556
International Association for the Study of Lung Cancer

RELATED STORIES:
A new way to look at lung cancer and tobacco carcinogens   Last-minute radiation saves lung cancer patients   Lung cancer slowed by Pfizer drug   Blood test may find early lung cancer: study   Learn the Signs and Symptoms of Lung Cancer   Gene variations directly link inflammation to an increased risk for lung cancer   UT Southwestern research uncovers genetic link between emphysema, lung cancer   Personalized treatment for early lung cancer   Non-Surgical Treatment Gives Lung Cancer Patients Three Years or More   Quitting Smoking After Lung Cancer Diagnosis Can Prolong Life   Women survive lung cancer better than men   Lung cancer patients need help to quit smoking   Missing protein may hold lung cancer key   More signs lung cancer screening could save lives   Quick, easy test identifies aggressive type of lung cancer in never-smokers   Lung Cancer Screening Encouraged for Smokers with History of the Disease   Who should get screened for lung cancer?   BATTLE Trial Personalizes Lung Cancer Therapy   Early Diagnosis of Lung Cancer: Where Do We Stand?   New lung cancer research finds half of advanced lung cancer patients receive chemotherapy   Elderly Dutch lung patients’ survival improved by new treatment options between 2003-2009   Women Catching Up to Men in Lung Cancer Deaths

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]